留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

冠状动脉瘤样扩张伴狭窄闭塞、抗磷脂抗体综合征、肾病综合征、多囊肾一例

王宇鑫 郭潇潇 杨德彦 赵久良 蒋颖 胡蓉蓉 沈东超 毛玥莹 王琳 严晓伟

王宇鑫, 郭潇潇, 杨德彦, 赵久良, 蒋颖, 胡蓉蓉, 沈东超, 毛玥莹, 王琳, 严晓伟. 冠状动脉瘤样扩张伴狭窄闭塞、抗磷脂抗体综合征、肾病综合征、多囊肾一例[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2021-0678
引用本文: 王宇鑫, 郭潇潇, 杨德彦, 赵久良, 蒋颖, 胡蓉蓉, 沈东超, 毛玥莹, 王琳, 严晓伟. 冠状动脉瘤样扩张伴狭窄闭塞、抗磷脂抗体综合征、肾病综合征、多囊肾一例[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2021-0678
WANG Yuxin, GUO Xiaoxiao, YANG Deyan, ZHAO Jiuliang, JIANG Ying, HU Rongrong, SHEN Dongchao, MAO Yueying, WANG Lin, YAN Xiaowei. Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome,Nephrotic Syndrome, and Polycystic Kidney:A Case Report[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2021-0678
Citation: WANG Yuxin, GUO Xiaoxiao, YANG Deyan, ZHAO Jiuliang, JIANG Ying, HU Rongrong, SHEN Dongchao, MAO Yueying, WANG Lin, YAN Xiaowei. Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome,Nephrotic Syndrome, and Polycystic Kidney:A Case Report[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2021-0678

冠状动脉瘤样扩张伴狭窄闭塞、抗磷脂抗体综合征、肾病综合征、多囊肾一例

doi: 10.12290/xhyxzz.2021-0678
详细信息
    通讯作者:

    郭潇潇,E-mail:xiaoxiaoguopumch@163.com

  • 中图分类号: R593;R692;R543.3+2

Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome,Nephrotic Syndrome, and Polycystic Kidney:A Case Report

  • 摘要: 患者青年男性,早发心肌梗死,合并多囊肾,存在肾病综合征及抗磷脂抗体综合征,冠状动脉造影示多支冠状动脉瘤样扩张伴狭窄闭塞,植入支架后出现支架内反复再狭窄。抗磷脂抗体综合征是反复冠状动脉血栓形成的危险因素,且可累及肾脏并导致肾病综合征;遗传性多囊肾可有肾病综合征的临床表现且可因基因异常合并动脉瘤样病变。遗传因素、免疫因素、代谢因素等均参与其中,经多学科讨论并结合随诊结果,考虑患者为结缔组织病继发抗磷脂抗体综合征、肾病综合征和冠状动脉病变,针对原发病治疗后患者症状及指标均好转。本例患者的诊治拓宽了临床医师对年轻患者冠状动脉疾病背后病因的认识,也体现了多学科诊疗临床思维的重要性。
  • [1] Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006, 4:295-306.
    [2] Meroni P L, Raschi E, Testoni C, et al. Antiphospholipid antibodies and the endothelium[J]. Rheum Dis Clin North Am, 2001, 27:587-602.
    [3] Pyo R, Lee J K, Shipley J M, et al. Targeted gene disruption of matrix metalloproteinase-9(gelatinase B) suppresses development of experimental abdominal aortic aneurysms[J]. J Clin Invest, 2000,105:1641-1649.
    [4] de Carvalho JF, Shoenfeld Y. Aneurysms in primary antiphospholipid syndrome:a case-based review[J]. Clin Rheumatol, 2021, 40:3001-3006.
    [5] Gracia-Tello B, Isenberg D. Kidney disease in primary anti-phospholipid antibody syndrome[J]. Rheumatology, 2017, 56:1069-1080.
    [6] Bienaimé F, Legendre C, Terzi F, et al. Antiphospholipid syndrome and kidney disease[J]. Kidney Int, 2017, 91:34-44.
    [7] Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome[J]. J Am Soc Nephrol, 1999, 10:507-518.
    [8] Ohara K, Kimura T, Karasawa T, et al. A large coronary aneurysm and its probable precursor lesions in a patient with autosomal dominant polycystic kidney disease:an implication for the process of aneurysmogenesis[J]. Pathol Int, 2012, 62:758-762.
    [9] Neves J B, Rodrigues F B, Lopes J A. Autosomal dominant polycystic kidney disease and coronary artery dissection or aneurysm:a systematic review[J]. Ren Fail, 2016, 38:493-502.
    [10] Visciano B, Di Pietro RA, Rossano R, et al. Nephrotic syndrome and autosomal dominant polycystic kidney disease[J]. Clin Kidney J, 2012, 5:508-511.
    [11] Aringer M, Costenbader K, Daikh D, et al.2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus[J].Arthritis Rheumatol, 2019, 71:1400-1412.
  • 加载中
计量
  • 文章访问数:  2
  • HTML全文浏览量:  0
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-10-03
  • 录用日期:  2021-11-26
  • 网络出版日期:  2022-08-01

目录

    /

    返回文章
    返回